Symyx Spurns Certara's $5.75-per-Share Offer Twice in One Week

Symyx also disclosed in filings with the US Securities and Exchange Commission this week that it has entered a memorandum of understanding to settle a class action suit filed by several of its shareholders regarding its impending merger agreement with Accelrys.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.